Journals / Dicle Tıp Dergisi / 2015 / Cilt: 42 - Sayı: 1

Use of artificial intelligence techniques for diagnosis of malignant pleural mesothelioma

Use of artificial intelligence techniques for diagnosis of malignant pleural mesothelioma Malign plevral mezotelyoma tanısı için yapay zeka teknikleri kullanımı

Pages
5–11
Publication Date
2015-05-09
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Key words: malignant pleural mesothelioma disease diagnosis, artificial immune system, machine learning based decision support system.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Malignant pleural mesothelioma is a highly aggressive tumor of the serous membranes, which in humans results from exposure to asbestos and asbestiform fibers.
📊
Key Findings & Data:Results: 97.74% accuracy performance is obtained by artificial immune system.
💡
Conclusion & Impact:Key words: malignant pleural mesothelioma disease diagnosis, artificial immune system, machine learning based decision support system.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Kötü huylu plevral mezotelyoma hastalığının teşhisi · yapay bağışıklık sistemi · makine öğrenme tabanlı karar destek sistemi

Abstract

Objective: Malignant pleural mesothelioma is a highly aggressive tumor of the serous membranes, which in humans results from exposure to asbestos and asbestiform fibers. The incidence of malignant mesothelioma is extremely high in some Turkish villages where there is a low-level environmental exposure to erionite, a fibrous zeolite. Therefore epidemiological studies are difficult to perform in Turkey. Methods: In this paper, a study on malignant pleural mesothelioma disease diagnosis was realized by using artificial immune system. Also, the artificial immune system result was compared with the result of the multi-layer neural network focusing on malignant pleural mesothelioma disease diagnosis and using same database. The malignant pleural mesothelioma disease dataset were prepared from a faculty of medicine’s database using patient’s hospital reports. Results: 97.74% accuracy performance is obtained by artificial immune system. The accuracy results of artificial immune system algorithm are much better than the accuracy results of multi-layer neural network algorithm. Conclusion: This system is capable of conducting the classification process with a good performance to help the expert while deciding the healthy and patient subjects. So, this structure can be helpful as learning based decision support system for contributing to the doctors in their diagnosis decisions. Key words: malignant pleural mesothelioma disease diagnosis, artificial immune system, machine learning based decision support system.

Özet

Amaç: İnsanların beyin zarında bulunan, asbestos ve asbestiform liflerine maruz kalmakla oluşan kötü huylu plevral Mezotelyoma, oldukça saldırgan bir tümördür. Düşük seviyeli çevresel erionite fibrous zeolite’e maruz bırakılmış Türkiye’deki bazı kasabalarda Mezotelyoma görülme oranı oldukça yüksektir.Yöntemler: Bu çalışmada Mezotelyoma hastalığı teşhisi yapay bağışıklık sistemi kullanımı ile gerçekleştirilmiştir. Bununla beraber yapay bağışıklık sistemi sonuçları, aynı veri tabanını kullanan, Mezotelyoma hastalığının teşhisine odaklanmış çok katmanlı yapay sinir ağı sonuçları ile karşılaştırılmıştır. Mezotelyoma hastalığı veri seti, hastaların hastane raporlarını kullanan tıp fakültesi veri tabanından alınmıştır.Bulgular: Yapay bağışıklık sistemi tarafından hastalık teşhisi için %97,74 doğruluk oranında bir performans elde edilmiştir. Yapay bağışıklık sistemi algoritmasının doğruluk sonuçları çok katmanlı yapay sinir ağı algoritmasından çok daha iyi olduğu görülmüştür.Sonuç: Bu sistem uzmana, sağlıklı ve hasta kişiyi sınıflandırma sürecinde doğru teşhisi bulma yönünde iyi bir performans sağlar. Böylece bu yapı ile doğru teşhis sonucuna ulaşmada doktorlara bir karar destek sistemi olarak yardımcı olur

🔖

Cite This Article

ER, O., TANRİKULU, A. Ç., ABAKAY, A. (2015). Use of artificial intelligence techniques for diagnosis of malignant pleural mesothelioma. Dicle Tıp Dergisi, Cilt: 42 - Sayı: 1, 5–11. https://ajindex.com/articles/485191

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Povince. Br J Indust Med 1960;17:266-271.
  2. Emri S, Akbulut H, Zorlu F, et al. Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma. Lung Cancer 2001; 33:109-114.
  3. Barış B, Demir AU, Shehu V, et al. Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. J Environ Pathol Toxicol Oncol 1996;:183-189.
  4. Dumortier P, Çöplü L, De Maertelaer V, et al. Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med 1998; 158:1815- - Selcuk ZT, Coplu L, Emri S, et al. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest 1992;102:790-796.
  5. Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic Brit J Cancer 1999;79:666-672.
  6. Burgers JA, Damhuis RAM, Prognostic factors in malignant mesothelioma Lung Cancer 2004;56:123-129.
  7. Zervos MD, Bizekis C. Pass HI: Malignant mesothelioma Curr Opin Pulm Med 2008, 14:303-309. National Mesothelioma committee, http://www.mesothelioma-tr.org/ (last accepted: 10 November 2014)
  8. Tanrikulu AC, Senyigit A, Dagli CE, et al. Environmental malignant pleural mesothelioma in Southeast Turkey. Saudi Med J 2006;27:1605-1607.
  9. Senyiğit A, Bayram H, Babayiğit C, et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients. Respiration 2000;67:615-622.
  10. Senyiğit A, Babayiğit C, Gökirmak M, et al. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey. Respiration;67:610-614.
  11. Can N, Puyan FÖ, Öz F, et al. Warthin-like papillary thyroid carcinoma: A rare tumor of the thyroid. Dicle Medical Journal;38:482-485.
  12. Alberts AS, Faikson G, Goedhals L, et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J. Clin Oncol 1988;6:527-535. Vogelzang NJ. Malignant mesothelioma: diagnostic and management strategies for 1992. Semin Oncol 1992;19:64- - Chailleux E, Dabouis G, Pioche D, et al. Prognostic factors in diffuse malignant pleural mesothelioma. Chest;93:159-162.
  13. Schouwink H, Korse CM, Bonfrer JM, et al. Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma. Lung Cancer;25:25-32.
  14. Sugarbaker D.J., Jaklitse